Canada · Delayed Price · Currency is CAD Satellos Bioscience Statistics
Total Valuation
TSX:MSCL has a market cap or net worth of CAD 105.78 million. The enterprise value is 53.66 million.
| Market Cap | 105.78M |
| Enterprise Value | 53.66M |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:MSCL has 176.31 million shares outstanding. The number of shares has increased by 26.47% in one year.
| Current Share Class | 176.31M |
| Shares Outstanding | 176.31M |
| Shares Change (YoY) | +26.47% |
| Shares Change (QoQ) | +3.26% |
| Owned by Insiders (%) | 9.49% |
| Owned by Institutions (%) | 1.79% |
| Float | 147.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.02 |
| P/TBV Ratio | 2.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.73 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.90 |
Financial Position
The company has a current ratio of 14.84
| Current Ratio | 14.84 |
| Quick Ratio | 13.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.43% and return on invested capital (ROIC) is -46.55%.
| Return on Equity (ROE) | -76.43% |
| Return on Assets (ROA) | -42.48% |
| Return on Invested Capital (ROIC) | -46.55% |
| Return on Capital Employed (ROCE) | -57.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.94M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TSX:MSCL has paid 129,567 in taxes.
| Income Tax | 129,567 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.00% in the last 52 weeks. The beta is 0.66, so TSX:MSCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +20.00% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 0.71 |
| Relative Strength Index (RSI) | 52.73 |
| Average Volume (20 Days) | 122,446 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -20.76M |
| Operating Income | -30.30M |
| Pretax Income | -30.96M |
| Net Income | -31.09M |
| EBITDA | -30.28M |
| EBIT | -30.30M |
| Earnings Per Share (EPS) | -0.22 |
Balance Sheet
The company has 52.12 million in cash and n/a in debt, giving a net cash position of 52.12 million or 0.30 per share.
| Cash & Cash Equivalents | 52.12M |
| Total Debt | n/a |
| Net Cash | 52.12M |
| Net Cash Per Share | 0.30 |
| Equity (Book Value) | 52.30M |
| Book Value Per Share | 0.30 |
| Working Capital | 52.29M |
Cash Flow
In the last 12 months, operating cash flow was -28.26 million and capital expenditures -4,636, giving a free cash flow of -28.27 million.
| Operating Cash Flow | -28.26M |
| Capital Expenditures | -4,636 |
| Free Cash Flow | -28.27M |
| FCF Per Share | -0.16 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:MSCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.47% |
| Shareholder Yield | n/a |
| Earnings Yield | -29.39% |
| FCF Yield | -26.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |